Headache in Children: Update on Complementary Treatments

 

 Permissions and Reprints

Abstract

Complementary and alternative medicine (CAM) is widely used by both physicians and patients with primary headache syndromes. Despite a considerable number of articles addressing CAM in primary headache syndromes, the overall evidence for CAM is still poor. The aim of this review was to give an overview of the current evidence of the main alternative therapies used in the treatment of primary headache syndromes of childhood. MEDLINE and Cochrane Library were systematically searched for articles dealing with complementary and alternative treatment or prophylaxis of headache and migraine published within the past 20 years.

• References

• 1 Ottolini MC, Hamburger EK, Loprieato JO , et al. Complementary and alternative medicine use among children in the Washington, DC area. Ambul Pediatr 2001; 1 (2) 122-125
  CrossrefPubMedGoogle Scholar
• 2 Smith C, Eckert K. Prevalence of complementary and alternative medicine and use among children in South Australia. J Paediatr Child Health 2006; 42 (9) 538-543
  CrossrefPubMedGoogle Scholar
• 3 Shenfield G, Lim E, Allen H. Survey of the use of complementary medicines and therapies in children with asthma. J Paediatr Child Health 2002; 38 (3) 252-257
  CrossrefPubMedGoogle Scholar
• 4 Gaul C, Eismann R, Schmidt T , et al. Use of complementary and alternative medicine in patients suffering from primary headache disorders. Cephalalgia 2009; 29 (10) 1069-1078
  CrossrefPubMedGoogle Scholar
• 5 Weissenstein A, Straeter A, Villalon G, Luchter E, Bittmann S. High frequency of CAM use among children in Germany. J Altern Complement Med 2012; 18 (8) 729-730
  CrossrefPubMedGoogle Scholar
• 6 Ernst ERK, Mills S, Hill R, Mitchell A, Willoughby M, White A. Complementary medicine—a definition. Br J Gen Pract 1995; 45 (398) 506
  PubMedGoogle Scholar
• 7 (NCCAM) NCfCaAM. What is complementary and alternative medicine (CAM)? NCCAM Publication No D347. Available at: http://nccam.nih.gov/health/whatiscam ; 2010
  PubMedGoogle Scholar
• 8 Eisenberg DM, Davis RB, Ettner SL , et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998; 280 (18) 1569-1575
  CrossrefPubMedGoogle Scholar
• 9 Häußermann D. Allensbach-Studie: Wachsendes Vertrauen in Naturheilmittel. Deutsches Ärzteblatt 1997; 94 (39) A2466-A2467
  PubMedGoogle Scholar
• 10 Termine C, Ozge A, Antonaci F, Natriashvili S, Guidetti V, Wöber-Bingöl C. Overview of diagnosis and management of paediatric headache. Part II. Therapeutic management. J Headache Pain 2011; 12 (1) 25-34
  CrossrefPubMedGoogle Scholar
• 11 Cheng X. Chinese Acupuncture and Moxibustion. Beijing: Foreign Languages Press; 1987
  Google Scholar
• 12 Bodeker G, Ong C, Grundy C, Burford G, Shein K. WHO Global Atlas of Traditional, Complementary and Alternative Medicine. Kobe: WHO Center for Health Development; 2005
  Google Scholar
• 13 Pomeranz B, Cheng R, Law P. Acupuncture reduces electrophysiological and behavioral responses to noxious stimuli: pituitary is implicated. Exp Neurol 1977; 54 (1) 172-178
  CrossrefPubMedGoogle Scholar
• 14 Takeshige C, Kobori M, Hishida F, Luo CP, Usami S. Analgesia inhibitory system involvement in nonacupuncture point-stimulation-produced analgesia. Brain Res Bull 1992; 28 (3) 379-391
  CrossrefPubMedGoogle Scholar
• 15 Takeshige C, Zhao WH, Guo SY. Convergence from the preoptic area and arcuate nucleus to the median eminence in acupuncture and nonacupuncture point stimulation analgesia. Brain Res Bull 1991; 26 (5) 771-778
  CrossrefPubMedGoogle Scholar
• 16 Lao L, Zhang RX, Zhang G, Wang X, Berman BM, Ren K. A parametric study of electroacupuncture on persistent hyperalgesia and Fos protein expression in rats. Brain Res 2004; 1020 (1-2) 18-29
  CrossrefPubMedGoogle Scholar
• 17 Ceccherelli F, Gagliardi G, Ruzzante L, Giron G. Acupuncture modulation of capsaicin-induced inflammation: effect of intraperitoneal and local administration of naloxone in rats. A blinded controlled study. J Altern Complement Med 2002; 8 (3) 341-349
  CrossrefPubMedGoogle Scholar
• 18 Jeong HJ, Hong SH, Nam YC , et al. The effect of acupuncture on proinflammatory cytokine production in patients with chronic headache: a preliminary report. Am J Chin Med 2003; 31 (6) 945-954
  CrossrefPubMedGoogle Scholar
• 19 Pintov S, Lahat E, Alstein M, Vogel Z, Barg J. Acupuncture and the opioid system: implications in management of migraine. Pediatr Neurol 1997; 17 (2) 129-133
  CrossrefPubMedGoogle Scholar
• 20 Gottschling S, Meyer S, Gribova I , et al. Laser acupuncture in children with headache: a double-blind, randomized, bicenter, placebo-controlled trial. Pain 2008; 137 (2) 405-412
  CrossrefPubMedGoogle Scholar
• 21 Linde K, Allais G, Brinkhaus B, Manheimer E, Vickers A, White AR. Acupuncture for migraine prophylaxis. Cochrane Database Syst Rev 2009; (1) CD001218
  PubMedGoogle Scholar
• 22 Linde K, Allais G, Brinkhaus B, Manheimer E, Vickers A, White AR. Acupuncture for tension-type headache. Cochrane Database Syst Rev 2009; (1) CD007587
  PubMedGoogle Scholar
• 23 Vickers AJ, Cronin AM, Maschino AC , et al; for the Acupuncture Trialists' Collaboration. Acupuncture for chronic pain: individual patient data meta-analysis. Arch Intern Med 2012; 172 (19) 1444-1453
  CrossrefPubMedGoogle Scholar
• 24 Melchart D, Thormaehlen J, Hager S, Liao J, Linde K, Weidenhammer W. Acupuncture versus placebo versus sumatriptan for early treatment of migraine attacks: a randomized controlled trial. J Intern Med 2003; 253 (2) 181-188
  CrossrefPubMedGoogle Scholar
• 25 Gottschling S, Gronwald B, Schmitt S , et al. Use of complementary and alternative medicine in healthy children and children with chronic medical conditions in Germany [published online ahead of print July 11, 2011]. Complement Ther Med 10.1016/j.ctim.2011.06.001
  PubMedGoogle Scholar
• 26 Hahnemann S. Organon der Heilkunst. Volume 6. Heidelberg, Germany: Huaug Verlag; 1999
  Google Scholar
• 27 Rey L. Can low-temperature thermoluminescence cast light on the nature of ultra-high dilutions?. Homeopathy 2007; 96 (3) 170-174
  Article in Thieme ConnectPubMedGoogle Scholar
• 28 Danno K, Colas A, Masson JL, Bordet MF. Homeopathic treatment of migraine in children: results of a prospective, multicenter, observational study. J Altern Complement Med 2012;
  PubMedGoogle Scholar
• 29 Muscari-Tomaioli G, Allegri F, Miali E , et al. Observational study of quality of life in patients with headache, receiving homeopathic treatment. Br Homeopath J 2001; 90 (4) 189-197
  Article in Thieme ConnectPubMedGoogle Scholar
• 30 Witt CM, Lüdtke R, Willich SN. Homeopathic treatment of patients with migraine: a prospective observational study with a 2-year follow-up period. J Altern Complement Med 2010; 16 (4) 347-355
  CrossrefPubMedGoogle Scholar
• 31 Walach H, Haeusler W, Lowes T , et al. Classical homeopathic treatment of chronic headaches. Cephalalgia 1997; 17 (2) 119-126 , discussion 101
  CrossrefPubMedGoogle Scholar
• 32 Whitmarsh TE, Coleston-Shields DM, Steiner TJ. Double-blind randomized placebo-controlled study of homoeopathic prophylaxis of migraine. Cephalalgia 1997; 17 (5) 600-604
  CrossrefPubMedGoogle Scholar
• 33 Straumsheim P, Borchgrevink C, Mowinckel P, Kierulf H, Hafslund O. Homeopathic treatment of migraine: a double blind, placebo controlled trial of 68 patients [see comment]. [see comment] Br Homeopath J 2000; 89 (1) 4-7
  Article in Thieme ConnectPubMedGoogle Scholar
• 34 Walach H, Lowes T, Mussbach D , et al. The long-term effects of homeopathic treatment of chronic headaches: one year follow-up and single case time series analysis. Br Homeopath J 2001; 90 (2) 63-72
  Article in Thieme ConnectPubMedGoogle Scholar
• 35 Frei H, Everts R, von Ammon K , et al. Randomised controlled trials of homeopathy in hyperactive children: treatment procedure leads to an unconventional study design. Experience with open-label homeopathic treatment preceding the Swiss ADHD placebo controlled, randomised, double-blind, cross-over trial. Homeopathy 2007; 96 (1) 35-41
  Article in Thieme ConnectPubMedGoogle Scholar
• 36 Jacobs J, Jonas WB, Jiménez-Pérez M, Crothers D. Homeopathy for childhood diarrhea: combined results and metaanalysis from three randomized, controlled clinical trials. Pediatr Infect Dis J 2003; 22 (3) 229-234
  PubMedGoogle Scholar
• 37 Mody I, Lambert JD, Heinemann U. Low extracellular magnesium induces epileptiform activity and spreading depression in rat hippocampal slices. J Neurophysiol 1987; 57 (3) 869-888
  PubMedGoogle Scholar
• 38 Baudouin-Legros M, Dard B, Guicheney P. Hyperreactivity of platelets from spontaneously hypertensive rats. Role of external magnesium. Hypertension 1986; 8 (8) 694-699
  CrossrefPubMedGoogle Scholar
• 39 Altura BT, Memon ZI, Zhang A , et al. Low levels of serum ionized magnesium are found in patients early after stroke which result in rapid elevation in cytosolic free calcium and spasm in cerebral vascular muscle cells. Neurosci Lett 1997; 230 (1) 37-40
  CrossrefPubMedGoogle Scholar
• 40 Coan EJ, Collingridge GL. Magnesium ions block an N-methyl-D-aspartate receptor-mediated component of synaptic transmission in rat hippocampus. Neurosci Lett 1985; 53 (1) 21-26
  CrossrefPubMedGoogle Scholar
• 41 Wang F, Van Den Eeden SK, Ackerson LM, Salk SE, Reince RH, Elin RJ. Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, double-blind, placebo-controlled trial. Headache 2003; 43 (6) 601-610
  CrossrefPubMedGoogle Scholar
• 42 Mauskop A, Altura BT, Altura BM. Serum ionized magnesium levels and serum ionized calcium/ionized magnesium ratios in women with menstrual migraine. Headache 2002; 42 (4) 242-248
  CrossrefPubMedGoogle Scholar
• 43 Facchinetti F, Sances G, Borella P, Genazzani AR, Nappi G. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache 1991; 31 (5) 298-301
  CrossrefPubMedGoogle Scholar
• 44 Peikert A, Wilimzig C, Köhne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia 1996; 16 (4) 257-263
  CrossrefPubMedGoogle Scholar
• 45 Köseoglu E, Talaslioglu A, Gönül AS, Kula M. The effects of magnesium prophylaxis in migraine without aura. Magnes Res 2008; 21 (2) 101-108
  PubMedGoogle Scholar
• 46 Pfaffenrath V, Wessely P, Meyer C , et al. Magnesium in the prophylaxis of migraine—a double-blind placebo-controlled study. Cephalalgia 1996; 16 (6) 436-440
  CrossrefPubMedGoogle Scholar
• 47 Cete Y, Dora B, Ertan C, Ozdemir C, Oktay C. A randomized prospective placebo-controlled study of intravenous magnesium sulphate vs. metoclopramide in the management of acute migraine attacks in the Emergency Department. Cephalalgia 2005; 25 (3) 199-204
  CrossrefPubMedGoogle Scholar
• 48 Koo B, Becker LE, Chuang S , et al. Mitochondrial encephalomyopathy, lactic acidosis, stroke-like episodes (MELAS): clinical, radiological, pathological, and genetic observations. Ann Neurol 1993; 34 (1) 25-32
  CrossrefPubMedGoogle Scholar
• 49 Lantéri-Minet M, Desnuelle C. [Migraine and mitochondrial dysfunction]. Rev Neurol (Paris) 1996; 152 (4) 234-238
  PubMedGoogle Scholar
• 50 Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology 1998; 50 (2) 466-470
  CrossrefPubMedGoogle Scholar
• 51 MacLennan SC, Wade FM, Forrest KM, Ratanayake PD, Fagan E, Antony J. High-dose riboflavin for migraine prophylaxis in children: a double-blind, randomized, placebo-controlled trial. J Child Neurol 2008; 23 (11) 1300-1304
  CrossrefPubMedGoogle Scholar
• 52 Bruijn J, Duivenvoorden H, Passchier J, Locher H, Dijkstra N, Arts WF. Medium-dose riboflavin as a prophylactic agent in children with migraine: a preliminary placebo-controlled, randomised, double-blind, cross-over trial. Cephalalgia 2010; 30 (12) 1426-1434
  CrossrefPubMedGoogle Scholar
• 53 Condò M, Posar A, Arbizzani A, Parmeggiani A. Riboflavin prophylaxis in pediatric and adolescent migraine. J Headache Pain 2009; 10 (5) 361-365
  CrossrefPubMedGoogle Scholar
• 54 Hershey AD, Powers SW, Vockell AL , et al. Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine. Headache 2007; 47 (1) 73-80
  PubMedGoogle Scholar
• 55 Slater SK, Nelson TD, Kabbouche MA , et al. A randomized, double-blinded, placebo-controlled, crossover, add-on study of coenzyme Q10 in the prevention of pediatric and adolescent migraine. Cephalalgia 2011; 31 (8) 897-905
  CrossrefPubMedGoogle Scholar
• 56 Eaton J. Butterbur, herbal help for migraine. Nat Pharm 1998; 2: 23-24
  PubMedGoogle Scholar
• 57 Oelkers-Ax R, Leins A, Parzer P , et al. Butterbur root extract and music therapy in the prevention of childhood migraine: an explorative study. Eur J Pain 2008; 12 (3) 301-313
  CrossrefPubMedGoogle Scholar
• 58 Pothmann R, Danesch U. Migraine prevention in children and adolescents: results of an open study with a special butterbur root extract. Headache 2005; 45 (3) 196-203
  CrossrefPubMedGoogle Scholar
• 59 Heptinstall S, White A, Williamson L, Mitchell JR. Extracts of feverfew inhibit granule secretion in blood platelets and polymorphonuclear leucocytes. Lancet 1985; 1 (8437) 1071-1074
  PubMedGoogle Scholar
• 60 Heptinstall S, Groenewegen WA, Spangenberg P, Loesche W. Extracts of feverfew may inhibit platelet behaviour via neutralization of sulphydryl groups. J Pharm Pharmacol 1987; 39 (6) 459-465
  CrossrefPubMedGoogle Scholar
• 61 Pugh WJ, Sambo K. Prostaglandin synthetase inhibitors in feverfew. J Pharm Pharmacol 1988; 40 (10) 743-745
  CrossrefPubMedGoogle Scholar
• 62 Makheja AN, Bailey JM. A platelet phospholipase inhibitor from the medicinal herb feverfew (Tanacetum parthenium). Prostaglandins Leukot Med 1982; 8 (6) 653-660
  PubMedGoogle Scholar
• 63 Draves A, Walker S. Parthenolide content of Canadian commercial feverfew preparations: label claims are misleading in most cases. Can Pharm J 2003; 136: 23-30 (RPC)
  PubMedGoogle Scholar
• 64 Willigmann I, Freudenstein J. Production of a Stable Feverfew (Tanacetum parthenium) Extract as an Active Substance for a Pharmaceutical Product. Vienna: Society for Medicinal Plant Research; 1998
  Google Scholar
• 65 Diener HC, Pfaffenrath V, Schnitker J, Friede M, Henneicke-von Zepelin HH. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention—a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia 2005; 25 (11) 1031-1041
  CrossrefPubMedGoogle Scholar
• 66 Beyer WF. Kopfschmerz—was ist osteopathische Medizin?. Manuelle Medizin 2001; 39: 301-303
  CrossrefPubMedGoogle Scholar
• 67 Borusiak P, Biedermann H, Bosserhoff S, Opp J. Lack of efficacy of manual therapy in children and adolescents with suspected cervicogenic headache: results of a prospective, randomized, placebo-controlled, and blinded trial. Headache 2010; 50 (2) 224-230
  CrossrefPubMedGoogle Scholar
• 68 Vernon H, McDermaid CS, Hagino C. Systematic review of randomized clinical trials of complementary/alternative therapies in the treatment of tension-type and cervicogenic headache. Complement Ther Med 1999; 7 (3) 142-155
  CrossrefPubMedGoogle Scholar
• 69 Nelson CF, Bronfort G, Evans R, Boline P, Goldsmith C, Anderson AV. The efficacy of spinal manipulation, amitriptyline and the combination of both therapies for the prophylaxis of migraine headache. J Manipulative Physiol Ther 1998; 21 (8) 511-519
  PubMedGoogle Scholar